This list is based on the watchlists of people on Stock Events who follow XSNX. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Show more...
FAQ
What is Novaccess Global stock price today?▼
The current price of XSNX is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Novaccess Global stock price performance more closely on the chart.
What is Novaccess Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Novaccess Global stocks are traded under the ticker XSNX.
Is Novaccess Global stock price growing?▼
XSNX stock has risen by +0% compared to the previous week, the month change is a +100% rise, over the last year Novaccess Global has showed a +0% increase.
What is Novaccess Global market cap?▼
Today Novaccess Global has the market capitalization of 12,330.4
What is Novaccess Global revenue for the last year?▼
Novaccess Global revenue for the last year amounts to 0 USD.
What is Novaccess Global net income for the last year?▼
XSNX net income for the last year is -2.66M USD.
How many employees does Novaccess Global have?▼
As of September 04, 2026, the company has 2 employees.
In which sector is Novaccess Global located?▼
Novaccess Global operates in the Health & Wellness sector.
When did Novaccess Global complete a stock split?▼
The last stock split for Novaccess Global was on August 26, 2020 with a ratio of 1:1000.
Where is Novaccess Global headquartered?▼
Novaccess Global is headquartered in New York, United States.